What temperature do compounded peptides actually need in transit?
Refrigerated peptide preparations need 2–8°C — but USP <659> does not require a perfectly flat line inside that band. The chapter’s definition of controlled cold temperature permits excursions between 2°C and 15°C for periods not exceeding 24 hours, provided the calculated mean kinetic temperature stays at or below 8°C and the product never goes below 2°C or above 15°C.
That is a materially different design target from the “2–8°C, zero tolerance” framing most packaging vendors publish. It is also still a demanding one, because 15°C is 59°F — a ceiling that ordinary parcel conditions blow through easily.
The reason this distinction matters is practical. A pharmacy that believes any reading above 8°C is an automatic failure will quarantine product it did not need to quarantine, over-spend on refrigerant, and misread its own validation data. A pharmacy that believes the 15°C allowance is a comfortable buffer will ship into summer conditions that break it within hours. Getting the actual standard right is what lets you design against it.
What USP <659> actually says
USP General Chapter <659>, Packaging and Storage Requirements, is the definitional chapter — it establishes what each storage term means. The relevant definitions for anyone shipping refrigerated preparations:
| Term | Range | Permitted excursion |
|---|---|---|
| Controlled cold temperature | 2–8°C 36–46°F |
Between 2°C and 15°C, not exceeding 24 hours, with calculated MKT not more than 8°C. No excursion below 2°C or above 15°C. |
| Controlled room temperature | 20–25°C 68–77°F |
Between 15°C and 30°C. |
| Freezer | −25 to −10°C −13 to 14°F |
— |
The controlled cold temperature definition carries one further provision that is widely quoted and widely misapplied: transient spikes up to 25°C may be permitted if the manufacturer so instructs, and if they do not exceed 24 hours.
For a commercially manufactured product, “the manufacturer” is the company whose stability data supports the allowance — and that data is why Ozempic’s labeling permits up to 30°C for 56 days after first use, and Mounjaro’s permits up to 30°C for 21 days. For a compounded preparation, you are the manufacturer. The 25°C allowance is only available to you if your own stability data supports it. Borrowing Novo Nordisk’s allowance for your compounded preparation is not a defensible position, because their data describes their formulation, not yours.
What real parcels actually do
The best available field data on the thermal environment a pharmacy parcel travels through comes from a prospective study published in the Journal of the American Pharmacists Association in 2023. Researchers shipped 36 packages fitted with data-logging thermometers between New Jersey, California, and Tennessee — three carriers, two shipping methods, three replicates — across both a winter and a summer window.
of transit time was spent outside the USP <659> controlled room temperature range — regardless of shipping method, carrier, or season.
Chowdhury et al., JAPhA, 2023. PMID 36858884
Read that number carefully, because it is frequently misused. The study shipped non-refrigerated product in ordinary mailers, and it measured against the room temperature range. It is not a statement about how validated cold chain shippers perform. What it establishes is the baseline hazard — the ambient environment your packout has to survive. Two-thirds of transit is spent outside a range that spans 68–77°F. A 2–15°C ceiling is far narrower than that.
Supporting field observations put the outer bounds in perspective: recorded delivery ambients span roughly −35°C to +35°C, spikes above 40°C are common, and sustained worst-case readings around 52.9°C have been documented. Journalists using in-cab thermometers have recorded 116–121°F inside delivery trucks during the 2022 heat waves (The Guardian, August 2022). Your packout is not being asked to hold 2–8°C in a warehouse. It is being asked to hold it in that.
The design target this implies
Translating the standard into a packout specification:
- Design to 2–8°C, not to 15°C. The excursion allowance is tolerance for the unexpected, not headroom to spend deliberately. A packout designed to land at 14°C has no margin left for a carrier delay.
- The 24-hour clock is cumulative exposure, not a single event. A lane with repeated short excursions is not automatically compliant because no individual excursion was long.
- The lower bound is a real constraint. No excursion below 2°C is permitted, and freezing is a hard discard under GLP-1 labeling. Adding refrigerant to solve a heat problem can create a freeze problem — see the freeze problem.
- Hold time must exceed transit time with margin. A 72-hour packout on a 72-hour lane has zero margin. Match hold time to worst-case transit, not to the carrier’s published estimate.
Meridian’s packouts are chamber-tested against summer-peak ambient profiles for the full duration of their rated hold — 48 hours for the M-48 and 72 hours for the M-72. We publish the tested figures rather than the aspirational ones, and we will run a lane test on your actual route before you commit to either.
What to do when a shipment lands warm
The excursion allowance is not self-executing. If a shipment arrives with a reading above 8°C, the question is whether the exposure fits inside the <659> envelope — which requires calculating mean kinetic temperature rather than eyeballing a peak. That calculation, and USP’s own explicit warning about its limits, is covered in how to adjudicate a temperature excursion.
Frequently asked questions
Is 2–8°C a hard limit for compounded peptides?
2–8°C is the storage requirement. USP <659> permits excursions between 2°C and 15°C for up to 24 hours during transport, provided calculated mean kinetic temperature remains at or below 8°C. It is not a hard limit in the sense of any reading above 8°C being an automatic failure, but the outer bound of 15°C is firm.
Can I rely on the 25°C transient spike allowance?
Only if the manufacturer’s instructions support it. For a compounded preparation, the pharmacy is the manufacturer, so the allowance is available only to the extent your own stability data justifies it. The room-temperature allowances printed on approved GLP-1 products reflect those sponsors’ formulations and stability programs, not yours.
How long can a compounded peptide sit above 8°C?
Under the <659> controlled cold temperature definition, excursions may not exceed 24 hours and may not go above 15°C, with calculated MKT at or below 8°C. Beyond those bounds you are outside the definition and the disposition decision falls to your own stability data and quality procedures. Be sceptical of specific hour-by-temperature figures for compounded peptides circulating online — most trace to marketing pages rather than to stability studies.
Does freezing ruin a peptide preparation?
For GLP-1 products, approved labeling treats freezing as a discard condition without qualification. USP <659> also permits no excursion below 2°C under controlled cold temperature. A frozen and thawed vial frequently looks normal, which makes this failure mode particularly dangerous.
What ambient temperature should I design my packout for?
Design for the seasonal extreme on your worst lane, not the average. Documented parcel environments include sustained readings above 40°C and in-cab delivery-truck readings of 116–121°F recorded by The Guardian (2022). Chamber validation should use a summer-peak profile, and the tested hold time should exceed worst-case transit with margin.
Does USP <659> apply to compounded preparations?
<659> defines the storage terms that other chapters, labeling, and state rules reference. Several state pharmacy rules require delivery within the temperature requirements recommended by the manufacturer or USP, which pulls these definitions in directly.
Find out what your lane actually does
We will ship a sample packout on your route, in your season, with the chamber test data alongside it. Judge the result, not the brochure.
Request a lane testSources
- USP General Chapter <659>, Packaging and Storage Requirements. See also USP-NF chapter documentation.
- Chowdhury et al., “Evaluation of temperature excursions from USP <659> recommendations during mail transit,” Journal of the American Pharmacists Association, 2023. PMID 36858884.
- Novo Nordisk, GLP-1 receptor agonist storage and stability information.
- USP General Chapter <1079>, Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products. USP.org.